UB spinout POP Biotechnologies receives up to $9.7 million for rapid-response vaccine platform
Funding will help Buffalo-based company advance a bird flu vaccine candidate and test its vaccine platform for future outbreak response.
Read the full articleYou might also wanna read
Purdue leads $2M USDA study on catmint oil to fight bird flu
Purdue leads $2M USDA study on catmint oil to fight bird flu Fogging technology targets airborne HPAI transmission in poultry houses
As Ebola Spreads, Scientists Race to Find Vaccines and Treatments
“CEPI is also awarding up to $50 million to Boston-based Moderna to create an mRNA vaccine for Bundibugyo… In 2018, Alexander Bukreyev, a vi
RQ Bio secures $115M Series A for virus-targeting antibody pipeline
RQ Bio has clinched $115 million in a Series A raise to advance a preclinical pipeline of virus-targeting antibodies.
endpoints.news·17d ago
Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs
California-based startup bets on AI-designed biologics that tackle complex diseases from multiple angles at once.
longevity.technology·1mo agoCanada funds $892K antimicrobial research for poultry health
Canada funds $892K antimicrobial research for poultry health Project targets E. coli and Salmonella alternatives to antibiotics
Biotech venture capital roundup: Osanni Bio leads with $190M Series B
Our latest roundup of venture capital financings in the biotech sector includes rounds for Osanni Bio, Bionyra, Serapha, Nura Bio, and Oblen
pharmaphorum.com·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.